(Q71819558)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Attenuation of Genetic Hypertension After Short-term Vasopressin V1A Receptor Antagonism (English)

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

30 May 2024

1 reference

antidiuretic hormone receptor antagonists

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591025

30 May 2024

6

C I Johnston

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

L M Burrell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

P. A. Phillips

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591025

30 May 2024

J. Risvanis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591025

30 May 2024

K. L. Aldred

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591025

30 May 2024

A. M. Hutchins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591025

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7591025

30 May 2024

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://www.ahajournals.org/doi/full/10.1161/01.HYP.26.5.828

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

30 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

828-834

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat

21 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Central role for vasopressin in cardiovascular regulation and the pathogenesis of hypertension

30 May 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Development of a new strain of spontaneously hypertensive rats homozygous for hypothalamic diabetes insipidus

30 May 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Attenuation of endothelin effects by a chloride channel inhibitor, indanyloxyacetic acid

30 May 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Attenuation of spontaneous hypertension in rats by a vasopressin antagonist

30 May 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Evidence against a pressor role for vasopressin in spontaneous hypertension

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term

30 May 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats

30 May 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat

30 May 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension

30 May 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

OPC-21268, a vasopressin V1 antagonist, produces hypotension in spontaneously hypertensive rats

30 May 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

American Journal of Physiology

30 May 2024

15

142

748

1988

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Clinical science and molecular medicine

30 May 2024

18

5

251s

1978

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Plasma Levels and Urinary Excretion of Nalidixic Acid in Patients with Renal Failure*

30 May 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Progesterone and EGF inhibit mouse mammary gland prolactin receptor and beta-casein gene expression

30 May 2024

21

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Effect of arginine vasopressin on renal medullary blood flow. A videomicroscopic study in the rat

30 May 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Vascular responses to vasopressin antagonists in man and rat.

30 May 2024

26

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat

30 May 2024

27

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells

30 May 2024

30

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells

30 May 2024

31

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

Inhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268

30 May 2024

32

1 reference

https://api.crossref.org/works/10.1161/01.HYP.26.5.828

30 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7591025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference